Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600267 stock hub

SHA/600267 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600267is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600267

In the news

Latest news · SHA/600267

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 17.1P50 24.2P75 37.8

Trailing P/E19.4

P25 23.5P50 41.3P75 83.2

ROEn/a

P25 -0.9P50 4.1P75 8.8

ROIC8.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600267 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

CNY

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	8,751
Employees Change	757%
Employees Change Percent	9.47
Enterprise value	CNY 15.3B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE0000013Z2
Last refreshed	2026-05-10
Market cap	CNY 13.4B
Price	CNY 11.55
Price currency	CNY
Rev Per Employee	1,177,955.74x
Sector	Healthcare
Sic	2833
Symbol	sha/600267
Website	https://www.hisunpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.23%
EV Earnings	21.79x
EV/EBIT	11.61x
EV/EBITDA	6.77x
EV/Sales	1.48x
Forward P/E	25.38x
P/B ratio	1.52x
P/E ratio	19.36x
P/S ratio	1.3x
PE Ratio10 Y	180.29x
PE Ratio3 Y	20.58x
PE Ratio5 Y	25.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.78%
EBITDA Margin	21.75%
Gross margin	42.39%
Gross Profit	CNY 4.4B
Gross Profit Growth	2.43%
Gross Profit Growth Q	115.58%
Gross Profit Growth3 Y	-4.26%
Gross Profit Growth5 Y	-2.41%
Net Income	CNY 702.2M
Net Income Growth	28.4%
Net Income Growth Q	83.13%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	6.21%
Net Income Growth5 Y	2.71%
Pretax Margin	10.17%
Profit Margin	6.81%
Profit Per Employee	CNY 80,239
Profitable Years	2
Roa5y	2.74
Roe5y	4.98
ROIC	8.49
Roic5y	4.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.45%
Cagr15y	-3.9%
Cagr1y	34.15%
Cagr20y	7.04%
Cagr3y	-1.93%
Cagr5y	-2.64%
Div CAGR10	6.68%
Div CAGR3	14.47%
Div CAGR5	33.24%
EPS Growth	26.14
EPS Growth Q	82.35
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	6.86
EPS Growth5 Y	-0.72
Revenue Growth	6.36x
Revenue Growth Q	-9.17x
Revenue Growth Years	1x
Revenue Growth3 Y	-5.26x
Revenue Growth5 Y	-2.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	CNY 1.3B
Debt	CNY 2.9B
Debt EBITDA	CNY 1.3
Debt Equity	CNY 0.33
Equity	CNY 8.9B
Interest Coverage	13.17
Net Cash	CNY -1.6B
Net Cash By Market Cap	CNY -12.27
Net Debt EBITDA	CNY 0.73
Net Debt Equity	CNY 0.19
Tangible Book Value	CNY 7.8B
Tangible Book Value Per Share	CNY 6.68
WACC	5.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.79%
Dividend Growth	0%
Dividend Growth Years	3%
Dividend per share	CNY 0.21
Dividend Years	1
Dividend Yield	1.82%
Last Dividend	CNY 0.21
Payout Ratio	35.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	4.58%
1Y total return	34.12%
200-day SMA	10.78
3Y total return	-5.69%
50-day SMA	10.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-12.54%
All Time High	28.31
All Time High Change	-59.2%
All Time High Date	2010-11-16
All Time Low	2.56
All Time Low Change	351.17%
All Time Low Date	2003-01-03
ATR	0.36
Beta	0.41
Beta1y	0.26
Beta2y	0.38
Ch YTD	16.79
High	11.67
High52	13.06
High52 Date	2025-07-11
High52ch	-11.56%
Low	11.45
Low52	8.66
Low52 Date	2025-05-16
Low52ch	33.37%
Ma50ch	8.48%
Price vs 200-day SMA	7.19%
RSI	60.94
RSI Monthly	60.55
RSI Weekly	63.79
Sharpe ratio	0.98x
Sortino ratio	1.88
Total Return	0.03%
Tr YTD	16.79
Tr15y	-44.97%
Tr1m	8.55%
Tr1w	-0.35%
Tr3m	10%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.3B
Operating Income Growth	76.55
Operating Income Growth Q	51.05
Operating Income Growth3 Y	9.19
Operating Income Growth5 Y	3.75
Operating margin	12.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	707,216,793%
Shares Insiders	0.07%
Shares Institutions	7.33%
Shares Out	1,161,368,796
Shares Qo Q	-7.83%
Shares Yo Y	1.79%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	35,191,321.6x
Bv Per Share	7.41
Ch10y	-2.28
Ch15y	-50.08
Ch1m	8.55
Ch1w	-0.35
Ch1y	30.95
Ch20y	241
Ch3m	10
Ch3y	-9.2
Ch5y	-16.91
Ch6m	5.67
Change	-0.6%
Change From Open	-0.26
Close	11.62
Days Gap	-0.34
Depreciation Amortization	924,066,801
Dollar Volume	250,286,432.6
Earnings Date	2026-08-25
EBIT	CNY 1.3B
EBITDA	CNY 2.2B
EPS	CNY 0.6
F Score	1
Fiscal Year End	December
Founded	1,956
Graham Number	9.97507
Graham Upside	-13.64
Income Tax	CNY 339.5M
Is Primary Listing	1
Last Earnings Date	2026-04-08
Last Report Date	2026-03-31
Last Split Date	2012-05-25
Last Split Type	Forward
Lynch Fair Value	CNY 2.98
Lynch Upside	-74.17
Ma150	10.58
Ma150ch	9.17%
Ma20	11.13
Ma20ch	3.78%
Next Earnings Date	2026-08-25
Open	11.58
Payment Date	2025-05-16
Position In Range	45.45
Price Date	2026-05-08
Price EBITDA	CNY 5.98
Ptbv Ratio	1.73
Relative Volume	0.62x
Revenue	10,308,290,656x
Tax By Revenue	3.29x
Tax Rate	32.38%
Tr20y	290.18%
Tr6m	5.67%
Volume	21,669,821

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600267 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.21 annual per share

Payout ratio

+35.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+33.2%

3 consecutive years of growth

Total shareholder yield

+0.0%

Dividend yield + buyback yield combined

Performance

SHA/600267 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600267?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.3%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.8%

Negative means the company is buying back shares.

Technical

SHA/600267 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.9

Neutral momentum band

Price vs 200-day MA

+7.2%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.98

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600267

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600267 stock rating?

sha/600267 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600267 analysis?

The full report lives at /stocks/sha/600267/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600267?

The latest report frames sha/600267 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600267 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.